This is a safety and efficacy study of JUVÉDERM® VOLIFT® with Lidocaine and Restylane® in Chinese adults with nasolabial folds.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
175
JUVÉDERM® VOLIFT® with lidocaine injected into the nasolabial fold on Day 1, with optional touch-up injections into the nasolabial fold on Month 1.
Restylane® injected into the nasolabial fold on Day 1, with optional touch-up injections into the nasolabial fold on Month 1.
China Japan Friendship Hospital
Beijing, China
Peking University Third Hospital
Beijing, China
General Hospital of Guangzhou Military Command of PLA
Guangzhou, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Guangzhou, China
Investigator's Assessment of Severity of Each Nasolabial Fold (NLF) on the 5-Point NLF Severity Scale (NLFSS)
Time frame: Month 6
Subject's Assessment of Procedural Pain on an 11-Point Scale
Time frame: Day 1
Investigator's Assessment of Each NLF on the 5-Point Global Aesthetic Improvement Scale (GAIS)
Time frame: Month 6
Subject's Assessment of Each NLF on the 5-Point GAIS
Time frame: Month 6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Shanghai 9th Hospital
Shanghai, China